logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Pharmaceutical
Filter

Pharmaceutical

Categories

Sectors

Locations

Exchange

西奈山 和铂医药 癌症 新冠病毒

Mount Sinai and Harbour BioMed Collaborate to Advance Novel Biotherapies for the Treatment of Cancer and Coronavirus COVID-19

Mar 6, 2020

Life Science

腾讯 微医 IPO

Tencent-backed WeDoctor invites banks to lead $1 billion Hong Kong IPO, sources say

Mar 6, 2020

Life Science

信诺 新冠病毒 测试

Healthcare Roundup – Global coronavirus cases approaching 100K, Cigna to waive member fees for coronavirus testing

Mar 6, 2020

Life Science

新冠病毒 生物制药

Coronavirus Stimulates Biopharma and Academia Research Activities and Collaborations

Mar 5, 2020

Life Science

上海挚盟医药 HBV

Shanghai Zhimeng Starts US Phase I Trial of Novel HBV Treatment

Mar 5, 2020

Life Science

再生元 Moderna 冠状病毒 药物 疫苗

Healthcare Roundup – Regeneron expects coronavirus med to be ready by August, Moderna advances coronavirus vaccine candidate into the clinic

Mar 4, 2020

Life Science

罗氏 Actemra 冠状病毒

China approves use of Roche arthritis drug for coronavirus patients

Mar 4, 2020

Life Science

英特尔 联想 华大基因

Intel, Lenovo Help BGI Genomics Speed Up Coronavirus Genome Analysis

Mar 4, 2020

Life Science

美联储 国家灾难计划 冠状病毒 礼来

Healthcare Roundup – Feds mull use of national disaster program for coronavirus care, Coronavirus outbreak to not affect supply of medicines

Mar 3, 2020

Life Science

115亿美元巨资!赛默飞世尔为何愿花大价收购Qiagen

Thermo Fisher Expands Diagnostics Capabilities with $11.5 Billion Takeover of Qiagen

Mar 3, 2020

Life Science

美国Abpro在亚洲上市免疫肿瘤学和眼科药物

Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets

Mar 3, 2020

Life Science

Schrödinger 谷歌 美国 冠状病毒计划

Healthcare Roundup – Schrödinger teams up with Google, U.S. authorities ramp up coronavirus plans

Mar 3, 2020

Life Science

即将上市销售,上海新型冠状病毒的抗体检测试剂成功完成一期临床试验

Maker of Covid-19 Test Kit in Shanghai Expects Sales Cert Soon

Mar 2, 2020

Life Science

吉利德 Forty Seven

Gilead to Acquire Immuno-Oncology Company Forty Seven for $4.9 Billion

Mar 2, 2020

Life Science

Generex 北京中华 冠状病毒 疫苗

Generex Signs Contract with Chinese Partners Beijing Zhonghua Investment Fund Management Co., LTD and Sinotek-Advocates International Industry Development (Shenzhen) Co., Ltd. to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccine Technology

Mar 2, 2020

Life Science

和铂医药 CLTA-4抗体

Harbour BioMed to Begin US Trials of CLTA-4 Antibody

Feb 28, 2020

Life Science

AIM ImmunoTech Forty Seven 吉利德科学 冠状病毒

Healthcare Roundup – AIM ImmunoTech gets China entry boost for coronavirus drug, Gilead Sciences approaches Forty Seven

Feb 27, 2020

Life Science

Ovation Science (CSE OVAT)

Ovation Ships First Order of DermSafe by Air to China to Help Combat the Coronavirus (COVID-19)  

Feb 27, 2020

Life Science

  • ‹‹ Previous
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada